{"product_id":"nad-copy","title":"PT - 141","description":"\u003cp class=\"MsoNormal\" style=\"margin-bottom: 9.0pt;\"\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003ePT-141 (Bremelanotide) is a synthetic cyclic peptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) studied for its central effects on the melanocortin system and sexual behavior. Unlike PDE5 inhibitors which act peripherally on vascular smooth muscle, PT-141 research focuses on direct central nervous system pathways affecting sexual motivation and arousal in preclinical models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin: 6.0pt 0in 5.0pt 0in;\"\u003e\u003cb\u003e\u003cspan style=\"font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #2e6da4;\"\u003eMechanism of Action\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eActivates melanocortin receptors (MC1R, MC3R, MC4R) in the hypothalamus and limbic system, studied for effects on sexual arousal pathways in animal models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eInvestigated for increases in dopaminergic activity in the mesolimbic system, influencing motivation-related neurobiology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eResearch suggests stimulation of nitric oxide synthesis in relevant neural circuits.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eStudies indicate activity regardless of vascular health status, distinguishing its mechanism from PDE5-based pharmacology.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin: 7.0pt 0in 5.0pt 0in;\"\u003e\u003cb\u003e\u003cspan style=\"font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #2e6da4;\"\u003eResearch Areas\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eHypoactive sexual desire disorder (HSDD) research; an FDA-approved indication exists for a subcutaneous formulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eErectile dysfunction biology, including cases studied alongside or in comparison to PDE5 inhibitor mechanisms.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eSexual dysfunction secondary to pharmacological interventions.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoListParagraph\" style=\"text-indent: -.25in; mso-list: l0 level1 lfo1; margin: 0in 0in 4.0pt .5in;\"\u003e\u003c!-- [if !supportLists]--\u003e\u003cspan style=\"mso-list: Ignore;\"\u003e•\u003cspan style=\"font: 7.0pt 'Times New Roman';\"\u003e        \u003c\/span\u003e\u003c\/span\u003e\u003c!--[endif]--\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial;\"\u003eCentral arousal pathway and melanocortin system research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin: 7.0pt 0in 4.0pt 0in;\"\u003e\u003cb\u003e\u003cspan style=\"font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #2e6da4;\"\u003ePresentation and Storage\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" style=\"margin-bottom: 3.0pt;\"\u003e\u003ci\u003e\u003cspan style=\"font-size: 11.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: Arial; color: #444444;\"\u003eSupplied as a lyophilized powder in a sealed vial containing 10mg of PT-141. Reconstitute with bacteriostatic water for laboratory use. Store at -20C.\u003c\/span\u003e\u003c\/i\u003e\u003c\/p\u003e","brand":"bioreverselabs.com","offers":[{"title":"Default Title","offer_id":45880839733421,"sku":null,"price":1450.0,"currency_code":"MXN","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0761\/1577\/1565\/files\/21.png?v=1775136935","url":"https:\/\/bioreverselabs.com\/products\/nad-copy","provider":"Bio Reverse Labs","version":"1.0","type":"link"}